Scout Bio Funding: $20M Raised, Series A (2023)

Scout Bio funding overview

Scout Bio is based in Philadelphia. Scout Bio has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Scout Bio runs through 2023; nothing later has been disclosed. Investors on record include Digitalis Ventures, RiverVest Venture Partners, GreenSpring Associates, Frazier Healthcare Partners, Adage Capital Management, Correlation Ventures. 6 distinct backers are named across the disclosed rounds.

Scout Bio at a glance

Total raised: $20M
Latest round: Series A
Latest round date: January 2023
Headquarters: Philadelphia
Notable investors: Digitalis Ventures, RiverVest Venture Partners, GreenSpring Associates, Frazier Healthcare Partners, Adage Capital Management, Correlation Ventures

Frequently asked about Scout Bio funding

How much has Scout Bio raised?: Scout Bio has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Scout Bio?: Digitalis Ventures, RiverVest Venture Partners, GreenSpring Associates, Frazier Healthcare Partners, Adage Capital Management, Correlation Ventures are named among the investors backing Scout Bio.
What was the latest Scout Bio funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is Scout Bio based?: Scout Bio is based in Philadelphia.
When did Scout Bio last raise?: The last disclosed Scout Bio round closed in January 2023 at Series A.

We update the Scout Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Philadelphia and their backers are listed below.

Scout Bio Funding: $20M Raised, Series A (2023)

Scout Bio funding overview

Scout Bio at a glance

Frequently asked about Scout Bio funding

Companies related to Scout Bio (36)

Browse related funding lists (8)